南美洲血浆分离市场预测至 2028 年 - COVID-19 影响和按产品(免疫球蛋白、白蛋白、凝血因子浓缩物、蛋白酶抑制剂和其他血浆产品)、应用(神经病学、免疫学、血液学、重症监护、肺病学和其他应用程序)和最终用户(医院和诊所、临床研究实验室和学术机构)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 116    |    Report Code: TIPRE00026280    |    Category: Life Sciences

South America Plasma Fractionation Market

市场介绍

用于估计血浆分离市场的 SAM 区域由国家组成例如巴西、阿根廷和 SAM 的其他国家。由于各国中风发病率上升以及医疗保健系统的发展加快,预计该地区将经历增长机会。由于该地区国家对肿瘤和脑动脉瘤的认识不断提高,预计该市场也会增长。

该地区的病例数量有所增加。 SAM 国家自 COVID-19 第二波疫情爆发以来。据国际护士理事会称,由于病毒传播率高,巴西卫生专业人员的死亡率高于其他国家。目前,SAM各国正在迅速增加抗击COVID-19的临床项目。在这种情况下,制药和生物制药公司正在强调开发新的治疗方法来治疗 COVID-19,这对市场产生了负面影响。此外,由于 SAM 多个国家实施封锁,血液和相关产品的供应也减少,因为人们无法走出家门进行献血。随着血液供应减少,血浆加工公司受到了不利影响。因此,COVID-19 的爆发可能会对市场增长产生负面影响。       

 

             

市场概况与动态

SAM 的血浆分离市场预计将从 2021 年的 19.5598 亿美元增长到 2028 年的 26.6387 亿美元;预计 2021 年至 2028 年复合年增长率为 4.5%。与代谢组学相关的市场参与者正在积极探索可能的创新技术,以促进研究人员和医疗保健,因为血浆中含有治疗疾病的基本成分,例如抗体。目前正在开展各种研究,探讨血浆在治疗传统方法难以治愈的疾病方面的可能应用。此外,人们对献血优势和血浆应用的认识不断提高,预计将为市场开辟新的空间。        

主要细分市场

< /p>

SAM 血浆分离市场分为产品、应用、最终用户和国家。 SAM 血浆分离市场根据产品分为免疫球蛋白、白蛋白、凝血因子浓缩物、蛋白酶抑制剂等。免疫球蛋白细分市场可能会在 2021 年占据最大的市场份额。SAM 血浆分离市场根据应用分为神经病学、免疫学、血液学、重症监护、肺病学等。 2021 年,神经病学领域可能会占据最大的市场份额。 SAM 血浆分离市场根据最终用户分为医院和诊所、临床研究实验室、学术机构。 2021年,医院和诊所部门可能会占据最大的市场份额。根据国家/地区,SAM 血浆分离市场分为巴西、阿根廷和 SAM 的其他地区。 2021 年,巴西占据最大市场份额。

主要来源和上市公司

准备本 SAM 血浆分馏市场报告时参考的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有 Bharat Serums and Vaccines Limited (BSV);生物制品实验室有限公司;生物测试公司; CSL有限公司;格里福尔斯,SA; Kedrion SpA;奥克塔制药公司;和 SK 等离子。          

原因购买报告

  • 了解 SAM 血浆分离市场格局并确定最重要的细分市场可能会保证丰厚的回报。
  • 了解 SAM 血浆分馏市场不断变化的竞争格局,保持领先地位。
  • 通过识别最有可能销售前景的细分市场,有效规划 SAM 血浆分离市场的并购和合作交易。
  • 帮助从敏锐的洞察力中做出明智的业务决策并对 SAM 血浆分馏市场各个细分市场的市场表现进行综合分析。
  • 获取 SAM 地区 2021-2028 年各个细分市场的市场收入预测。< /span>

SAM

血浆分馏市场

细分

SAM 血浆分馏市场 -

按产品

  • 免疫球蛋白
    • 静脉注射免疫球蛋白(IVIG)
    • 皮下注射免疫球蛋白(SCIG) )
  • 白蛋白
  • 浓缩凝血因子
  • < li>蛋白酶抑制剂
  • 其他

SAM 血浆分离市场-

申请

  • 神经病学
  • 免疫学
  • 血液学
  • 重症监护
  • 肺病学
  • 其他

SAM 血浆分馏市场 - 结束用户

  • 医院和诊所
  • 临床研究实验室
  • 学术机构

SAM 血浆分馏市场 - 按国家/地区

  • 巴西
  • 阿根廷
  • 其他国家SAM

SAM 血浆分馏市场 - 公司简介

  • Bharat Serums and Vaccines Limited (BSV)
  • Bio Products Laboratory Ltd.
  • Biotest AG。< /li>
  • CSL 有限公司
  • Grifols, SA
  • Kedrion SpA
  • Octapharma AG
  • SK 血浆

 



South America Plasma Fractionation Strategic Insights

Strategic insights for South America Plasma Fractionation involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-america-plasma-fractionation-market-strategic-framework.webp
Get more information on this report

South America Plasma Fractionation Report Scope

Report Attribute Details
Market size in 2021 US$ 1,955.98 Million
Market Size by 2028 US$ 2,663.87 Million
Global CAGR (2021 - 2028) 4.5%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By 产品
  • 免疫球蛋白
  • 白蛋白
  • 凝血因子浓缩物
  • 蛋白酶抑制剂
  • 其他血浆产品
By 应用
  • 神经病学
  • 免疫学
  • 血液学
  • 重症监护
  • 肺病学
  • 其他应用
By 最终用户
  • 医院和诊所
  • 临床研究实验室
  • 学术机构
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • Bharat Serums and Vaccines Limited (BSV)
  • Bio Products Laboratory Ltd.
  • Biotest AG.
  • CSL Limited
  • Grifols, S.A.
  • Kedrion S.p.A
  • Octapharma AG
  • SK Plasma
  • Get more information on this report

    South America Plasma Fractionation Regional Insights

    The regional scope of South America Plasma Fractionation refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-america-plasma-fractionation-market-geography.webp
    Get more information on this report

    The List of Companies - South America Plasma Fractionation Market

    1. Bharat Serums and Vaccines Limited (BSV)
    2. Bio Products Laboratory Ltd.
    3. Biotest AG.
    4. CSL Limited
    5. Grifols, S.A.
    6. Kedrion S.p.A
    7. Octapharma AG
    8. SK Plasma
    Frequently Asked Questions
    How big is the South America Plasma Fractionation Market?

    The South America Plasma Fractionation Market is valued at US$ 1,955.98 Million in 2021, it is projected to reach US$ 2,663.87 Million by 2028.

    What is the CAGR for South America Plasma Fractionation Market by (2021 - 2028)?

    As per our report South America Plasma Fractionation Market, the market size is valued at US$ 1,955.98 Million in 2021, projecting it to reach US$ 2,663.87 Million by 2028. This translates to a CAGR of approximately 4.5% during the forecast period.

    What segments are covered in this report?

    The South America Plasma Fractionation Market report typically cover these key segments-

  • 产品 (免疫球蛋白, 白蛋白, 凝血因子浓缩物, 蛋白酶抑制剂, 其他血浆产品)
  • 应用 (神经病学, 免疫学, 血液学, 重症监护, 肺病学, 其他应用)
  • 最终用户 (医院和诊所, 临床研究实验室, 学术机构)
  • What is the historic period, base year, and forecast period taken for South America Plasma Fractionation Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Plasma Fractionation Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in South America Plasma Fractionation Market?

    The South America Plasma Fractionation Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Bharat Serums and Vaccines Limited (BSV)
  • Bio Products Laboratory Ltd.
  • Biotest AG.
  • CSL Limited
  • Grifols, S.A.
  • Kedrion S.p.A
  • Octapharma AG
  • SK Plasma
  • Who should buy this report?

    The South America Plasma Fractionation Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South America Plasma Fractionation Market value chain can benefit from the information contained in a comprehensive market report.